Fig. 1From: Metabolic inhibition of meloxicam by specific CYP2C9 inhibitors in Cunninghamella blakesleeana NCIM 687: in silico and in vitro studiesVirtual screening for interaction of specific CYP29 inhibitors (a–d) clopidogrel, Fenofibrate, fluvoxamine, sertraline with human CYP2C9 (PDB code: 1OG2) enzyme by molecular dockingBack to article page